Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.
Pyrimethamine-sulfadoxine, the first choice for uncomplicated falciparum malaria in Africa, exerts strong selection pressure for resistance because of its slow elimination. It is likely that resistance will emerge rapidly, and there is no widely affordable replacement. Chlorproguanil-dapsone is chea...
Main Authors: | Amukoye, E, Winstanley, P, Watkins, WM, Snow, R, Hatcher, J, Mosobo, M, Ngumbao, E, Lowe, B, Ton, M, Minyiri, G, Marsh, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1997
|
Similar Items
-
Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.
by: Winstanley, P, et al.
Published: (1997) -
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
by: Sulo, J, et al.
Published: (2002) -
Chlorproguanil-dapsone for malaria in Africa.
by: Looareesuwan, S, et al.
Published: (2004) -
A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated Plasmodium falciparum malaria.
by: Fanello, C, et al.
Published: (2008) -
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.
by: Zul Premji, et al.
Published: (2009-08-01)